Marathon Capital Management’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-296,025
Closed -$782K 168
2025
Q1
$782K Buy
296,025
+70,375
+31% +$282K 0.21% 70
2024
Q4
$957K Sell
225,650
-45,950
-17% -$177K 0.24% 70
2024
Q3
$902K Sell
271,600
-5,500
-2% -$18.7K 0.22% 71
2024
Q2
$856K Buy
277,100
+6,285
+2% +$20.7K 0.22% 73
2024
Q1
$1.09M Buy
270,815
+13,900
+5% +$52.4K 0.26% 69
2023
Q4
$1.44M Sell
256,915
-28,750
-10% -$165K 0.36% 65
2023
Q3
$1.52M Buy
285,665
+36,575
+15% +$297K 0.38% 61
2023
Q2
$2.33M Sell
249,090
-74,700
-23% -$656K 0.58% 47
2023
Q1
$2.8M Buy
323,790
+72,650
+29% +$641K 0.69% 42
2022
Q4
$1.78M Buy
251,140
+24,690
+11% +$207K 0.49% 45
2022
Q3
$2.25M Buy
226,450
+200
+0.1% +$1.81K 0.64% 39
2022
Q2
$1.61M Buy
226,250
+55,375
+32% +$404K 0.52% 43
2022
Q1
$1.58M Buy
170,875
+13,975
+9% +$105K 0.45% 51
2021
Q4
$1.47M Buy
+156,900
New +$1.46M 0.34% 53

Other funds holding DCGO

Marathon Capital Management's DCGO Position: Q2 2025 in Review

Marathon Capital Management sold out of DocGo (DCGO) in Q2 2025, closing a stake of 296,025 shares — an estimated $782K sold.

Marathon Capital Management first reported a position in DCGO in Q4 2021 and held it in 14 quarters. The position peaked at $2.8M in Q1 2023. 121 funds tracked by Wall St. Rank hold DCGO as of Q2 2025.

  • Marathon Capital Management reported no remaining DocGo position as of Q2 2025 after selling out during the quarter.
  • Marathon Capital Management sold 296,025 DocGo shares in Q2 2025, an estimated $782K.
  • Marathon Capital Management first reported a position in DocGo in Q4 2021 and held it in 14 quarters.
  • Marathon Capital Management's DocGo position peaked at $2.8M in Q1 2023.
  • 121 funds tracked by Wall St. Rank held DocGo as of Q2 2025.

Based on Marathon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.